In the BioHarmony Drug Report Database
Gralise, Neurontin (gabapentin) is a small molecule pharmaceutical. Gabapentin was first approved as Gralise on 1993-12-30. It is used to treat bipolar disorder, epilepsy, partial epilepsies, phobic disorders, and postherpetic neuralgia in the USA. It is known to target potassium voltage-gated channel subfamily KQT member 3 and potassium voltage-gated channel subfamily KQT member 5. Gabapentin’s patents are valid until 2024-02-26 (FDA).
Image (chem structure or protein)